• 제목/요약/키워드: 글루포시네이트

검색결과 11건 처리시간 0.031초

글루포시네이트 암모늄 중독 환자의 확산자기공명영상 소견: 증례 보고 (Diffusion-Weighted Imaging for Detecting Glufosinate Ammonium Intoxication: A Case Report)

  • 김형엽;박노혁
    • 대한영상의학회지
    • /
    • 제83권6호
    • /
    • pp.1354-1359
    • /
    • 2022
  • 글루포시네이트 암모늄은 세계적으로 널리 사용되는 제초제로서, 글루포시네이트 암모늄을 함유하는 제초제의 사용이 증가하면서 그에 따른 급성중독 사례도 증가하고 있는 추세이다. 이에 저자들은 글루포시네이트 암모늄 중독 후 발견되는 뇌 확산자기공명영상 소견에 대해 보고하고자 한다. 증례에서 환자는 양측 속섬유막, 중간소뇌다리, 뇌량팽대에서 세포독성부종 소견을 보였다.

급성 글루포시네이트 암모니움 중독 후 양측성 해마 병변과 전향적 기억상실증을 보인 증례 1례 보고 (A Case of Anterograde Amnesia with Bilateral Hippocampus Involvement After Acute Glufosinate Ammonium Intoxication)

  • 윤성원;김호균;이희중
    • Investigative Magnetic Resonance Imaging
    • /
    • 제18권4호
    • /
    • pp.352-356
    • /
    • 2014
  • 본 증례의 51세 남자 환자는 글루포시네이트 암모니움을 과다 섭취한 후에 전향적 기억상실증이 발생하였다. 뇌 자기공명영상에서 양측 해마와 해마옆이랑, 오른쪽 후두엽에서 고신호강도 병변을 관찰할 수 있었다. 급성 글루포시네이트 암모니움 중독이 해마에 병변을 만드는 기전과, 양측성 해마에서 생길 수 있는 질환들의 감별진단에 대하여 논하고자 한다.

LC-MS/MS를 이용한 동물 사료 내 글라이포세이트 및 글루포시네이트 분석 (Analysis of Glyphosate and Glufosinate in Animal Feeds using LC-MS/MS)

  • 이지수;김완서;양희득;박나연;정웅;김정환;고영림
    • 대한화학회지
    • /
    • 제63권5호
    • /
    • pp.342-345
    • /
    • 2019
  • 식품에서 글라이포세이트와 글루포시네이트의 함량 기준은 구체적이며 분류가 잘 되어있다. 그러나 동물 사료나 먹이에서의 함량 기준은 비교적 구체적이지 못하며 분류가 미흡한 편이다. 또한 인간에게 미치는 위험에 대해서는 지속적인 논의는 이루어지고 있는 반면에, 동물에게 미치는 위험성은 충분한 연구가 이루어지지 않았다. 본 연구에서는 동물이 글라이포세이트를 섭취하는 경로로 추정되는 사료에서의 분석법을 확립하였다. 25% 메탄올을 이용한 용매추출, 원심분리 후 고체상추출로 정제한 후, 농축하여 LC-MS/MS를 이용하여 정량 분석하였다. 분석법 검증은 검출한계, 정확도 및 정밀도 시험을 통해 진행하였다. 확립된 시험법의 검출한계는 글루포시네이트 $1.8{\mu}g/kg$, 글라이포세이트 $2.4{\mu}g/kg$ 이었다. 정확도는 94.4~103.4%, 정밀도는 1.5~7.2%의 범위로 나타났다. 동물 사료(n=13)를 분석법을 적용시켜 분석한 결과 글루포시네이트는 한 개의 시료에서 검출되었고($ND{\sim}8.8{\mu}g/kg$), 글라이포세이트는 한 개의 시료를 제외한 모든 시료에서 검출($ND{\sim}337.0{\mu}g/kg$)되었다.

급성 글루포시네이트 중독 후 서로 다른 예후를 보인 2례: 증례보고 (Two Cases of Acute Glufosinate Ammonium Intoxication with Disparate Outcomes)

  • 한홍준;정주호
    • 농촌의학ㆍ지역보건
    • /
    • 제43권2호
    • /
    • pp.108-113
    • /
    • 2018
  • 목적 글루포시네이트암모늄은 비선택성 제초제로 1984년 일본에서 개발되었으며, 급성 중독시에는 위장관계 증상뿐만 아니라 의식변화, 경련, 호흡부전 및 기억소실 등과 같은 다양한 임상증상을 보이는 것으로 알려져 있다. 한국에는 1994년 소개된 이후로 널리 사용되고 있으며, 사용량의 증가와함께 음독환자가 점점 증가하여 사회적 문제가 되고 있다. 저자들은 최근 글로포시네이트 중독 환자에서 초기치료 후 지연성 악화를 보였던 2례를 문헌고찰과 함께 보고하고자 한다. 방법 및 결과 첫 번째 증례는 62세의 남자환자로 음주상태에서 글루포시네이트암모늄 음독 후 의식 저하 상태로 발견되어 응급실로 이송되었다. 응급 위세척을 시행 후 보존적 치료 및 집중모니터링을 유지하였고, 의식수준은 6시간 후에 거의 명료한 상태로 호전되었다. 지연성 악화의 가능성에 대해설명하고 지속적인 경과관찰 및 치료를 위해 집중치료실 입원이 필요함에 대해 설명하였으나, 환자와 보호자는 타상급병원으로의 전원을 원하였다. 환자는 이송 중에 발생한 심폐정지로 심폐소생술을 시행하였으나, 회복되지 못하고 사망하였다. 두 번째 증례는 54세의 남자 환자로 글루포시네이트암모늄 음독 후 발생한 의식 변화로 응급실로 이송되었다. 내원시 의식은 혼미한 상태였으며 앞의 증례와 같이 응급 위세척을 시행하였다. 본 환자는 초기치료 후 본원 집중치료실에서 지속적인 혈액 및 생화학적 검사를 시행하였으며, 집중모니터링 및 치료를 유지하였다. 입원 2일째 혈액검사 소견은 호전 중이었으나, 경련이 발생하였으며 의식은 혼미한 상태가 지속되었다. 신경과 협진하여 뇌파검사를 시행 후 항경련제를 증량한 후로 경련은 발생하지 않았다. 입원 7일째에는 의식 수준은 거의 명료한 상태까지 호전되었다. 입원 13일째 혈액 및 생화학검사에서 약간의 혈색소 감소 외에는 정상소견을 보였으며, 뚜렷한 신경학적 합병증 없이 퇴원하였다. 결론 급성 글루포시네이트중독 환자는 매우 다양한 임상증상을 보이며 초기치료 후에 상태가 안정적이더라도 지연성으로 임상적 또는 신경학적 악화가 발생할 가능성이 있으므로 치료에 유의하여야 한다.

글루포시네이트 암모늄 중독환자에서 경련 예측인자로서의 혈중 지질 농도의 유용성 (The Usefulness of Serum Lipid Concentration as a Predictor of Convulsion in Patients with Glufosinate Ammonium Poisoning)

  • 이현도;선경훈;김성중
    • 대한임상독성학회지
    • /
    • 제15권1호
    • /
    • pp.40-46
    • /
    • 2017
  • Purpose: Glufosinate ammonium (GA; phosphinothricin) can induce neurological complications such as altered mental status, amnesia, and convulsions. This study was conducted to evaluate whether blood lipid profiles can help predict convulsions in patients with GA poisoning. Methods: This study was a retrospective review of data acquired at a tertiary academic university hospital from March 2014 to July 2016. Independent t-test, Mann-Whitney test and Analysis of covariance (ANCOVA) of demographic and laboratory findings of 50 patients with GA poisoning were performed to identify correlations of general characteristics and laboratory findings, including blood lipid profiles of GA-poisoned patients between with and without convulsions. Results: Convulsion as a GA complication showed a significant association with poison volume, age, white blood cell count, and creatine phosphokinase (CK), albumin, lactate dehydrogenase (LDH), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) content in blood according to an independent t-test and Mann-Whitney test. However, ANCOVA demonstrated significant association with LDL and triglyceride. Conclusion: Blood lipid profiles, especially serum LDL and triglyceride, were useful in predicting convulsions in patients with GA poisoning.

급성 글루포시네이트 암모늄 중독환자에서 혈중 Neuron specific enolase 수치와 경련발생 간의 연관성 (Relationship between Serum Neuron Specific Enolase Level and Seizure in Patients with Acute Glufosinate Ammonium Poisoning)

  • 안교진;이윤석;차용성;김현
    • 대한임상독성학회지
    • /
    • 제16권1호
    • /
    • pp.49-56
    • /
    • 2018
  • Purpose: Glufosinate ammonium poisoning can cause seizures, even after a symptom-free period. This study was conducted to evaluate the relationship between serum neuron specific enolase (NSE) level and the occurrence of seizures in patients with acute glufosinate ammonium poisoning. Methods: For this retrospective observational study, data from patients diagnosed with acute glufosinate ammonium poisoning were collected between January 2016 and June 2016. Serum NSE was measured within 2 hours of arrival at the emergency department. The patients were divided into a seizure group and a non-seizure group. Results: The seizure group included eight of the 15 total patients (53.3%). The serum NSE level was significantly higher in the seizure group than in the non-seizure group ($32.4{\pm}11.9ng/mL$ vs. $19.5{\pm}5ng/mL$, p=0.019). The amount of glufosinate ingested and initial and peak serum ammonia levels were significantly higher in the seizure group than in the non-seizure group. There was no significant difference in the area under the curve of the serum NSE level or the initial and peak serum ammonia levels in terms of predicting the occurrence of seizures. Conclusion: In acute glufosinate poisoning, initial serum NSE levels may help in prediction of seizures.

단일 응급의료기관에서 경험한 글루포시네이트 암모니움 포함 제초제 중독 후 중증도 예측에 관한 연구 (A Study of Predicting the Severity Following Glufosinate Ammonium Containing Herbicide Poisoning Experienced in Single Emergency Medical Institution)

  • 이두성;최경호
    • 대한임상독성학회지
    • /
    • 제17권1호
    • /
    • pp.7-13
    • /
    • 2019
  • Purpose: Owing to the increased agricultural use of the herbicide glufosinate ammonium (GLA), the incidence of GLA poisoning has recently increased. Therefore, we investigated the possible predictive factors associated with severe complications following GLA poisoning. Methods: A retrospective analysis of medical records was conducted based on 76 patients who had visited our regional emergency medical center with GLA poisoning from 2006 to 2017. Severe complications were defined as respiratory failure requiring intubation, systolic blood pressure less than 90 mmHg, Glasgow Coma Scale (GCS) less than 8, and presence of seizure. Results: Age, ingested amount and ingested amount per weight were significantly greater in the severe group (p<0.001). PSS grade 2 or higher was more common in the severe group (p<0.001), and In addition, the APACHE II score was significantly higher in the severe group (p<0.001), as were the SOFA scores (p=0.002). Serum ammonia levels were significantly higher in the severe group (p=0.007), while MDRD-GFR was smaller in the severe group (p=0.002). The spot urine protein levels were significantly higher in the severe group (p=0.005), as was the urine protein to creatinine ratio (p=0.001). Upon multivariate analysis, the amount ingested per weight and PSS grade 2 or higher were identified as significant predictors. Conclusion: Our study showed that MDRD-GFR was significantly lower in the severe group after GLA poisoning. PSS grade 2 or higher and ingested amount per weight may be useful to evaluate the severity of complications after GLA poisoning.

글루포시네이트 암모늄 제초제 중독환자에서 혈중 암모니아 농도와 사망률과의 연관성에 대한 연구 (Initial Serum Ammonia as a Predictor of Mortality in Patients with Acute Glufosinate Ammonium Herbicide Poisoning)

  • 고은나래;김동훈;이수훈;정진희;이상봉;성애진;서자현;강창우
    • 대한임상독성학회지
    • /
    • 제18권2호
    • /
    • pp.136-140
    • /
    • 2020
  • Purpose: The association of the initial serum ammonia level with in-hospital mortality in patients with acute glufosinate-ammonium herbicide poisoning was studied. Methods: This retrospective cohort study was conducted between March 2012 and August 2019 in the emergency department after glufosinate-ammonium herbicide poisoning. Survivors and non-survivors were analyzed using a Mann-Whitney U test and Fisher's exact test. Multivariate logistic regression analysis was performed to determine the independent risk factors for mortality. Results: One hundred and six patients were enrolled; 11 died, yielding a mortality of 10.4%. The serum bicarbonate level was significantly lower in the non-survival group than the survival group. Age, serum ammonia, blood urea nitrogen, creatinine levels, SOFA score, and APACHE II score were significantly higher in the non-survival group than the survival group. Age, serum ammonia, and creatinine level were independent risk factors for mortality in multivariate logistic regression analysis. Conclusion: The initial serum ammonia level is associated with mortality in patients with acute glufosinate herbicide poisoning.

글루포시네이트 중독 후 심장독성의 다양한 임상경과를 보인 1례 (A case of various clinical aspects associated with cardiotoxicity after glufosinate poisoning)

  • 김선태
    • 대한임상독성학회지
    • /
    • 제19권2호
    • /
    • pp.133-138
    • /
    • 2021
  • Glufosinate-containing herbicides is a non-selective herbicide commonly used worldwide. As the use of them increased gradually since paraquat was banned in 2012, the number of suicides by their ingestion is also increasing continuously. Complications of glufosinate-containing herbicide poisoning include various central nervous system (CNS) toxicities such as convulsions, loss of consciousness, memory impairment, and respiratory depression, which may be accompanied by hemodynamic changes such as bradycardia and hypotension. However, it is very rare that arrhythmias other than bradycardia occurred and Takotsubo cardiomyopathy was combined due to cardiotoxicity. A 71-year-old female patient was transferred to our hospital after ingesting 500 mL of glufosinate-containing herbicide and receiving 5 L of gastric lavage at a local hospital. A few hours later, she presented stuporous mentality, respiratory depression, and convulsions, and was accompanied by hypotension and bradycardia. On the second day of admission, electrocardiogram (ECG) showed bradycardia and QTc prolongation with hemodynamic Instability. Accordingly, we conducted the early treatment with continuous renal replacement therapy (CRRT) and the application of temporary cardiac pacemaker. An echocardiogram demonstrated decreased ejection fraction (EF) and Takotsubo cardiomyopathy on the third day of admission. Then, she was discharged safely with conservative treatment. At the follow-up after 1 year, Takotsubo cardiomyopathy, EF and QTc prolongation were recovered on echocardiogram and ECG. Because cardiac toxicity after glufosinate-containing herbicide poisoning may cause life-threatening consequences, caution is required while treating the patient. Therefore, if electrocardiogram changes are seen in the elderly with a large amount of glufosinate herbicide ingestion, additional cardiac function test through echocardiography should be concerned, and early treatment through CRRT or artificial cardiac pacing should be considered.

의식이 명료한 글루포시네이트 중독환자의 신경학적 예후인자로서 APACHE II의 유용성 (Utility of the APACHE II score as a neurological prognostic factor for glufosinate-intoxicated patients with alert mental status)

  • 이록;신태용;문형준;이현정;정동길;이동욱;홍선인;김현준
    • 대한임상독성학회지
    • /
    • 제21권2호
    • /
    • pp.135-142
    • /
    • 2023
  • Purpose: In patients with glufosinate poisoning, severe neurological symptoms may be closely related to a poor prognosis, but their appearance may be delayed. Therefore, this study aimed to determine whether the Acute Physiology and Chronic Health Evaluation II (APACHE II) score could predict the neurological prognosis in patients with glufosinate poisoning who present to the emergency room with alert mental status. Methods: This study was conducted retrospectively through a chart review for patients over 18 years who presented to a single emergency medical center from January 2018 to December 2022 due to glufosinate poisoning. Patients were divided into groups with a good neurological prognosis (Cerebral Performance Category [CPC] Scale 1 or 2) and a poor prognosis (CPC Scale 3, 4, or 5) to identify whether any variables showed significant differences between the two groups. Results: There were 66 patients (67.3%) with good neurological prognoses and 32 (32.8%) with poor prognoses. In the multivariate logistic analysis, the APACHE II score, serum amylase, and co-ingestion of alcohol showed significant results, with odds ratios of 1.387 (95% confidence interval [CI], 1.027-1.844), 1.017 (95% CI, 1.002-1.032), and 0.196 (95% CI, 0.040-0.948), respectively. With an APACHE II score cutoff of 6.5, the AUC was 0.826 (95% CI, 0.746-0.912). The cutoff of serum amylase was 75.5 U/L, with an AUC was 0.761 (95% CI, 0.652-0.844), and the AUC of no co-ingestion with alcohol was 0.629 (95% CI, 0.527-0.722). Conclusion: The APACHE II score could be a useful indicator for predicting the neurological prognosis of patients with glufosinate poisoning who have alert mental status.